The role of ERBB4 in cancer remains controversial, with evidence for both oncogenic (Junttila et al, 2005; Prickett et al, 2009) and tumour suppressor activities (Das et al, 2010; Sartor et al, 2001). The gene discussed is ERBB4; the disease is neoplasm.